Medicare Enrolled
Dr. Mark Vogel, MD
Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vogel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vogel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vogel
Dr. Mark Vogel is an urology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vogel performed 1,688 Medicare services across 1,108 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vogel received a total of $8,517 from 52 pharmaceutical and/or device companies across 235 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vogel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 44% volume in CA
$8,517 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,688
Medicare services
Top 44% in CA for urology physician
1,108
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~89 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
499 | $3 | $40 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
192 | $9 | $99 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $68 | $127 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $101 | $160 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
179 | $46 | $84 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
84 | $143 | $226 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
79 | $145 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
58 | $8 | $30 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $100 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $64 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $122 | $300 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
30 | $0 | $20 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
20 | $51 | $150 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $124 | $425 |
| Release of scar tissue at ureter A procedure to remove scar tissue from the ureter to restore normal urine flow. |
11 | $625 | $8,182 |
| New patient office visit, complex (60-74 min) | 11 | $172 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
12.2% medium
86.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,517
Total received (2018-2024)
Avg $1,217/year across 7 years
Top 23% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
235
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,426 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$922
2023
$810
2022
$1,056
2021
$691
2020
$693
2019
$1,901
2018
$2,443
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$146
BIOTISSUE HOLDINGS INC.
$108
PROCEPT BioRobotics Corporation
$105
PFIZER INC.
$78
PROGENICS PHARMACEUTICALS, INC.
$74
Sumitomo Pharma America, Inc.
$63
Baxter Healthcare
$57
Myriad Genetic Laboratories, Inc.
$55
ABBVIE INC.
$53
Becton, Dickinson and Company
$49
Blue Earth Diagnostics Limited
$49
Astellas Pharma US Inc
$25
Telix Pharmaceuticals
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
ACCORD HEALTHCARE, INC.
$19
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$1,499
Astellas Pharma US Inc
$1,191
PFIZER INC.
$436
Teleflex LLC
$430
Dendreon Pharmaceuticals LLC
$395
Antares Pharma, Inc.
$354
NeoTract Inc.
$348
Blue Earth Diagnostics Limited
$308
PROCEPT BioRobotics Corporation
$273
Janssen Biotech, Inc.
$246
TOLMAR Pharmaceuticals, Inc.
$236
UroGen Pharma, Inc.
$227
Acerus Pharmaceuticals Corporation
$226
Allergan Inc.
$194
Amgen Inc.
$180
Endo Pharmaceuticals Inc.
$161
Myriad Genetic Laboratories, Inc.
$142
BioTissue Holdings, Inc.
$138
Smith+Nephew, Inc.
$116
BIOTISSUE HOLDINGS INC.
$108
Baxter Healthcare
$95
Avadel Specialty Pharmaceuticals, LLC
$88
Boston Scientific Corporation
$84
PROGENICS PHARMACEUTICALS, INC.
$74
ACCORD HEALTHCARE, INC.
$64
Aytu BioScience, Inc
$63
Sumitomo Pharma America, Inc.
$63
Coloplast Corp
$60
AbbVie Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$57
Osiris Therapeutics Inc.
$54
ABBVIE INC.
$53
Becton, Dickinson and Company
$49
UROVANT SCIENCES INC
$41
COLOPLAST CORP
$38
UroViu Corporation
$38
EDAP TECHNOMED INC
$34
Progenics Pharmaceuticals, Inc.
$25
Hollister Incorporated
$25
Ferring Pharmaceuticals Inc.
$24
Verity Pharmaceuticals Inc.
$24
Merck Sharp & Dohme LLC
$22
Olympus America Inc.
$21
Telix Pharmaceuticals
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
UROGEN PHARMA, INC.
$18
AstraZeneca Pharmaceuticals LP
$17
Sagent Pharmaceuticals, Inc.
$17
Metuchen Pharmaceuticals
$17
Mission Pharmacal Company
$15
Profound Medical Corp.
$13
Zyla Life Sciences, Inc.
$12
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · ELIGARD · ERLEADA · EVENITY · Erleada · FLOSEAL · GEMTESA · GENERAL BPH · GENERAL BPH · GRAFIX · GRAFIX/GRAFIXPL/STRAVIX · Glydo · ILLUCCIX · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · OTREXUP · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SPEEDICATH · SPRIX · STELARA · STRAVIX · SpeediCath · Stendra · TISSEEL · TOVIAZ · Trelstar · Uribel · Uro-G Flexible Cystoscope · UroLift · UroLift System · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
385
Per 100K population
3.9
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vogel is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vogel experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Vogel performed 499 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vogel receive payments from pharmaceutical companies?
Yes. Dr. Vogel received a total of $8,517 from 52 companies across 235 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vogel's costs compare to other urology physicians in Los Angeles?
Dr. Vogel's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vogel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Los Angeles
Browse urology physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology